Nordic Society of Gynecologic Oncology
The NSGO (Nordic Society of Gynecological Oncology), a non-profit organization, was founded 1986. The mission of NSGO is to be a Nordic platform for professionals dedicated to the care of women with gynecological cancer, to work for improvements in the practice of gynecological cancer, to promote and support basic and clinical research, to promote education and training in gynecological oncology and to promote and support Nordic and international exchange among professionals and societies active in gynecologic oncology.
NSGO CTU was founded in 2005 to strengthen the performance of clinical trials and is one of the major European trial organizations in gynecologic oncology. Please visit our website, www.nsgo.org, for continuous update on past and current clinical trials.
Randomized trial of Avastin plus single-agent chemotherapy in platin-resistant ovarian cancer (GINECO-Aurelia)
Randomized phase III study of pazopanib versus control as maintenance therapy after first-line paclitaxel-carboplatin in ovarian cancer (AGO-OVAR16)
Randomized phase III of BI1120 versus placebo in combination with and maintenance therapy after first-line paclitaxel-carboplatin in ovarian cancer to replace the ICON-7 trial (AGO-OVAR12)
* If you are unable to view PDF files, please download a free PDF Reader from Adobe's website.